Gordon Wiegand

2.8k total citations · 1 hit paper
36 papers, 2.4k citations indexed

About

Gordon Wiegand is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Gordon Wiegand has authored 36 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Immunology. Recurrent topics in Gordon Wiegand's work include Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (4 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Gordon Wiegand is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (4 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Gordon Wiegand collaborates with scholars based in United States, China and Switzerland. Gordon Wiegand's co-authors include Augustine M.K. Choi, William Matthews, Ihor R. Lemischka, Craig T. Jordan, J Alam, Jawed Alam, Russell L. Margolis, Akira Sawa, Jillian K. Cooper and Christopher A. Ross and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gordon Wiegand

33 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations

1991 484 citations William Matthews, Craig T. Jordan et al. Cell profile →

Peers

Countries citing papers authored by Gordon Wiegand

Since Specialization

Citations

This map shows the geographic impact of Gordon Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Wiegand more than expected).

Fields of papers citing papers by Gordon Wiegand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Wiegand. The network helps show where Gordon Wiegand may publish in the future.

Co-authorship network of co-authors of Gordon Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Wiegand. A scholar is included among the top collaborators of Gordon Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Wiegand. Gordon Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerating Transition To Virtual Research Organisation In Social Science (AVROSS) 2019 ·Gordon Wiegand	0
2	Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells 2018 ·BMC Cancer ·Dandan Li, John E. Mullinax, Taylor Aiken, Hong-Wu Xin, Gordon Wiegand, Andrew J. Anderson, Snorri S. Thorgeirsson, Itzhak Avital, Udo Rudloff	17
3	Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin 2016 ·Journal of Cancer ·Hong-Wu Xin, (unknown), (unknown), Jin‐Qiu Chen, Gordon Wiegand, Andrew J. Anderson, Satyajit Ray, John E. Mullinax, Danielle M. Hari, Tomotake Koizumi, (unknown), Paul K. Goldsmith, Alexander Stojadinovic, Udo Rudloff, Snorri S. Thorgeirsson, Itzhak Avital	22
4	Wnt and the Cancer Niche: Paracrine Interactions with Gastrointestinal Cancer Cells Undergoing Asymmetric Cell Division 2013 ·Journal of Cancer ·Hong-Wu Xin, (unknown), Satyajit Ray, (unknown), Tomotake Koizumi, Gordon Wiegand, Danielle M. Hari, John E. Mullinax, Kshama Jaiswal, Susan H. Garfield, Alexander Stojadinovic, Udo Rudloff, Snorri S. Thorgeirsson, Itzhak Avital	18
5	Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells 2012 ·Cancer Research ·Mary Zhang, Aarti Mathur, Yuwei Zhang, Sichuan Xi, Scott M. Atay, Julie A. Hong, (unknown), Trevor Upham, Clinton D. Kemp, R. Taylor Ripley, Gordon Wiegand, (unknown), Patricia Fetsch, Haresh Mani, Daniel Zlott, Robert W. Robey, Susan E. Bates, Xinmin Li, Mahadev Rao, David S. Schrump	82
6	Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies 2012 ·Journal of Cancer ·Satyajit Ray, Russell C. Langan, John E. Mullinax, Tomotake Koizumi, Hong-Wu Xin, Gordon Wiegand, (unknown), Alexander Stojadinovic, Snorri S. Thorgeirsson, Udo Rudloff, Itzhak Avital	16
7	A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers 2012 ·Journal of Cancer ·Russell C. Langan, John E. Mullinax, Satyajit Ray, Manish T. Raiji, Nicholas P. Schaub, Hong-Wu Xin, Tomotake Koizumi, Seth M. Steinberg, Andrew J. Anderson, Gordon Wiegand, Donna Butcher, Miriam R. Anver, Anton J. Bilchik, Alexander Stojadinovic, Udo Rudloff, Itzhak Avital	48
8	Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells 2012 ·Stem Cell Research ·Kshama Jaiswal, Hong-Wu Xin, Andrew J. Anderson, Gordon Wiegand, Bo Kim, (unknown), Danielle M. Hari, Satyajit Ray, Tomotake Koizumi, Udo Rudloff, Snorri S. Thorgeirsson, Itzhak Avital	19
9	Isolation of Live Label-Retaining Cells and Cells Undergoing Asymmetric Cell Division via Nonrandom Chromosomal Cosegregation from Human Cancers 2011 ·Stem Cells and Development ·Danielle M. Hari, Hong-Wu Xin, Kshama Jaiswal, Gordon Wiegand, (unknown), (unknown), (unknown), Tomotake Koizumi, Satyajit Ray, Susan H. Garfield, Snorri S. Thorgeirsson, Itzhak Avital	32
10	E-INFRASTRUCTURE ADOPTION IN THE SOCIAL SCIENCES AND HUMANITIES 2010 ·Information Communication & Society ·Franz Barjak, Julia Lane, Meik Poschen, Rob Procter, Simon Robinson, Gordon Wiegand	3
11	Abstract 11: Asymmetric division via nonrandom chromosomal cosegregation potentially defines a novel class of universal cancer stem cells 2010 ·Cancer Research ·Hong-Wu Xin, Danielle M. Hari, Kshama Jaiswal, (unknown), Satyajit Ray, Tomotake Koizumi, Gordon Wiegand, Seth M. Steinberg, Susan H. Garfield, Jesper B. Andersen, Valentina M. Factor, Snorri S. Thorgeirsson, Itzhak Avital	5
12	A Functional Mouse Retroposed Gene Rps23r1 Reduces Alzheimer's β-Amyloid Levels and Tau Phosphorylation 2009 ·Neuron ·Yun‐wu Zhang, Shijie Liu, Xue Zhang, (unknown), Yaomin Chen, Xiumei Huang, Liangwu Sun, Wenjie Luo, William J. Netzer, (unknown), Gordon Wiegand, Ruishan Wang, Stanley N. Cohen, Paul Greengard, Francesca-Fang Liao, Limin Li, Huaxi Xu	32
13	The Restricted Expression of Granzyme M in Human Lymphocytes 2001 ·The Journal of Immunology ·Thomas J. Sayers, Alan D. Brooks, Jerrold M. Ward, Tomoaki Hoshino, (unknown), Gordon Wiegand, (unknown), Mark J. Smyth	77
14	Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization 1999 ·Nature Medicine ·Akira Sawa, Gordon Wiegand, Jillian K. Cooper, Russell L. Margolis, (unknown), Joseph F. Lawler, J. Timothy Greenamyre, Solomon H. Snyder, Christopher A. Ross	468
15	Transcriptional Activation of the HO-1 Gene by Lipopolysaccharide Is Mediated by 5′ Distal Enhancers: Role of Reactive Oxygen Intermediates and AP-1 1998 ·American Journal of Respiratory Cell and Molecular Biology ·Sharon L. Camhi, Jawed Alam, Gordon Wiegand, Beek Yoke Chin, Augustine M.K. Choi	111
16	Fluorescent erythrocyte ghosts as standards for quantitative flow cytometry 1995 ·Cytometry ·Stephen K. Doberstein, Gordon Wiegand, Laura M. Machesky, Thomas D. Pollard	11
17	Calcium mediates expression of stress‐response genes in prostaglandin A ₂ ‐induced growth arrest 1994 ·The FASEB Journal ·Augustine M.K. Choi, Robert W. Tucker, Sara Carlson, Gordon Wiegand, (unknown)	37
18	Inhibition of contractile vacuole function in vivo by antibodies against myosin-I 1993 ·Nature ·Stephen K. Doberstein, Ivan Baines, Gordon Wiegand, Edward D. Korn, Thomas D. Pollard	106
19	A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations breakdown → 1991 ·Cell ·William Matthews, Craig T. Jordan, Gordon Wiegand, (unknown), Ihor R. Lemischka	484
20	Biochemical events associated with inhibition of B-cell proliferation by phorbol diesters 1988 ·International Journal of Immunopharmacology ·Dori R. Germolec, George C. Clark, (unknown), Gordon Wiegand, Michael I. Luster	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact